logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yukio Hosomi

komagome hospital
H指数:34
被引数:9,223

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical outcomes and genomic features of uncommon EGFR exon 19 deletion subtypes in osimertinib-treated non-small cell lung cancer

奥希替尼治疗非小细胞肺癌中少见EGFR外显子19缺失亚型的临床结局与基因组特征

Lung Cancer
IF4.4
2026-08-310
PRE
Hiroto Hatano; Tatsuya Yoshida; Ryoko Inaba Higashiyama; Masayuki Shirasawa; Yoshiro Nakahara; Katsuhiko Naoki; Hiroshi Nokihara; Kentaro Gosho; Yuji Uehara; Yukio Hosomi; Ayu Kiritani; Hiroshi Wakui; Yuki Shinno; Yusuke Okuma; Hidehito Horinouchi; Noboru Yamamoto; Yasushi Goto
Disease Kinetics and Practice Patterns in ≥4-Year Long-Term Beneficiaries of Immune Checkpoint Inhibitors for Advanced Non-small Cell Lung Cancer

晚期非小细胞肺癌免疫检查点抑制剂≥4年长期受益者的疾病动力学与实践模式

Journal of Thoracic Oncology
IF20.8
2026-07-280
PRE
Masahiro Torasawa; Yoshihiro Masui; Keita Miura; Shunichi Kataoka; Masayuki Shirasawa; Yoshiro Nakahara; Junko Baba; Hidenobu Ishii; Maiko Asai; Tomoiki Aiba; Hiroshi Wakui; Shunichi Sugawara; Yukio Hosomi; Hiroshi Tanaka; Katsuhiko Naoki; Kazuhisa Takahashi; Hirotsugu Kenmotsu; Hidehito Horinouchi
Predicting Radiation-Induced Esophagitis in Locally Advanced NSCLC Using Baseline Clinical Factors: A Model from the Japan Lung Cancer Society Integrated Phase II–III Database

基于日本肺癌协会整合的II–III期数据库，利用基线临床因素预测局部晚期非小细胞肺癌的放射性食管炎

Clinical Lung Cancer
IF3.3
2026-04-240
PRE
Yuji Uehara; Kageaki Watanabe; Jun Tamura; Yuichi Ozawa; Makiko Yomota; Keigo Kishino; Takayuki Kobayashi; Kentaro Taguchi; Keiko Nemoto Murofushi; Satoshi Oizumi; Katsuyuki Hotta; Tsuneo Shimokawa; Seiji Niho; Shunichi Sugawara; Isamu Okamoto; Koji Yamamoto; Nobuyuki Yamamoto; Yukio Hosomi
Corrigendum to ‘Gut Microbiota in Advanced NSCLC Receiving Chemoimmunotherapy: An Ancillary Biomarker Study From the Phase III Trial JCOG2007 (NIPPON)’ [Journal of Thoracic Oncology Vol. 20 No. 7 (2025) 912–927]

勘误：‘Gut Microbiota in Advanced NSCLC Receiving Chemoimmunotherapy: An Ancillary Biomarker Study From the Phase III Trial JCOG2007 (NIPPON)’ [Journal of Thoracic Oncology Vol. 20 No. 7 (2025) 912–927]

Journal of Thoracic Oncology
IF20.8
2025-10-070
PRE
Taiki Hakozaki; Kentaro Tanaka; Yoshimasa Shiraishi; Yuta Sekino; Noriko Mitome; Yusuke Okuma; Tomoiki Aiba; Takahiro Utsumi; Junko Tanizaki; Koichi Azuma; Satoshi Hara; Ryo Morita; Seiji Niho; Toshihide Yokoyama; Ryo Toyozawa; Hidehito Horinouchi; Isamu Okamoto; Yukio Hosomi; Yuichiro Ohe
Phase III study of ramucirumab plus docetaxel versus atezolizumab for previously treated PD-L1 low or negative advanced non-small-cell lung cancer: WJOG10317L study

拉姆昔利单抗联合多西他赛对比阿特珠单抗治疗既往接受过治疗的PD-L1低表达或阴性晚期非小细胞肺癌的III期研究：WJOG10317L研究

Lung Cancer
IF4.4
2025-06-230
PRE
Yoshitaka Zenke; Seiji Niho; Yukihiro Toi; Masafumi Yamaguchi; Satoshi Hara; Yuki Akazawa; Yukio Hosomi; Kimio Yonesaka; Hiroaki Akamatsu; Toshihide Yokoyama; Junko Tanizaki; Kiyonobu Ueno; Hiroshi Gyotoku; Toshihiro Misumi; Kazuhiko Nakagawa; Nobuyuki Yamamoto; Masahiro Tsuboi
Efficacy of EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer with EGFR exon 19 insertions: clinical-genomic, preclinical analysis through LC-SCRUM-Asia (multi-institutional genomic screening registry)

EGFR酪氨酸激酶抑制剂在携带EGFR外显子19插入突变的非小细胞肺癌患者中的疗效：基于LC-SCRUM-Asia（多机构基因组筛查登记）的临床-基因组学及体外研究分析

LUNG CANCER
IF4.4
2025-04-010
OAAI
Uehara, Yuji; Izumi, Hiroki; Kobayashi, Ikei S.; Matsumoto, Shingo; Hosomi, Yukio; Okuno, Takae; Sugisaka, Jun; Takase, Naoto; Taima, Kageaki; Sasaki, Shinichi; Teranishi, Shuhei; Miyamoto, Shingo; Mori, Masahide; Nakashima, Chiho; Asano, Shuichi; Oi, Hajime; Sakai, Tetsuya; Shibata, Yuji; Udagawa, Hibiki; Sugiyama, Eri; Nosaki, Kaname; Umemura, Shigeki; Zenke, Yoshitaka; Yoh, Kiyotaka; Ikeda, Sadakatsu; Costa, Daniel B.; Kobayashi, Susumu; Goto, Koichi
Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in EGFR-Mutated Lung Adenocarcinoma

肿瘤相关成纤维细胞中实性占优势的组织学和podotlanin的高表达可预测EGFR突变的肺腺癌对奥希替尼的原发性耐药

JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2025-03-011
OA
Uehara, Yuji; Izumi, Hiroki; Taki, Tetsuro; Sakai, Tetsuya; Udagawa, Hibiki; Sugiyama, Eri; Umemura, Shigeki; Zenke, Yoshitaka; Matsumoto, Shingo; Yoh, Kiyotaka; Kubota, Shoko; Aokage, Keiju; Sakamoto, Naoya; Sakashita, Shingo; Kojima, Motohiro; Nagamine, Michiko; Hosomi, Yukio; Tsuboi, Masahiro; Goto, Koichi; Ishii, Genichiro
Synchronous Oligometastasis and Oligoprogression as a Prognostic Marker in Patients With Extensive-Stage SCLC Treated With a Combination of Immune-Checkpoint Inhibitor and Chemotherapy (HOT2301)
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2024-11-012
OA
Hashimoto, Kana; Morinaga, Daisuke; Asahina, Hajime; Ishidoya, Mina; Kikuchi, Hajime; Yokouchi, Hiroshi; Harada, Toshiyuki; Honjo, Osamu; Shigaki, Ryota; Takashina, Taichi; Fujita, Yuka; Takahashi, Mamoru; Kawai, Yasutaka; Kida, Ryotaro; Ito, Kenichiro; Sukoh, Noriaki; Takahashi, Ayumu; Hommura, Fumihiro; Ohhara, Yoshihito; Furuta, Megumi; Konno, Satoshi; Hosomi, Yukio; Oizumi, Satoshi
A phase III study comparing weekly carboplatin plus nabpaclitaxel and daily low-dose carboplatin for concurrent chemoradiotherapy in elderly patients (≥75 years) with unresectable locally advanced NSCLC: JCOG1914

一项比较每周卡铂联合nabpaclitaxel与每日低剂量卡铂用于老年患者（≥75岁）不可切除局部晚期NSCLC同期化放疗的III期研究：JCOG1914

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Omori, S.; Kenmotsu, H.; Takahashi, T.; Nomura, S.; Harada, H.; Ishikura, S.; Ando, M.; Izumi, H.; Shinno, Y.; Oki, M.; Masuda, T.; Yokoyama, T.; Hosomi, Y.; Shimokawa, T.; Murakami, S.; Kurosaki, T.; Yoshioka, H.; Mitome, N.; Fukuda, H.; Ohe, Y.
Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non-small-Cell Lung Cancer in Patients Aged 75 Years and Older
CLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
2024-06-173
OAAI
Yagishita, Shigehiro; Yamanaka, Yuta; Kurata, Takayasu; Watanabe, Kageaki; Hosomi, Yukio; Horinouchi, Hidehito; Ohe, Yuichiro; Nakahara, Yoshiro; Naoki, Katsuhiko; Asao, Tetsuhiko; Takahashi, Kazuhisa; Saeki, Sho; Sakagami, Takuro; Nakashima, Kazuhisa; Tsubata, Yukari; Fujita, Yu; Wakui, Hiroshi; Furuta, Megumi; Konishi, Jun Sakakibara; Ohuchi, Mayu; Ando, Yuichi; Mizugaki, Hidenori; Hamada, Akinobu
Promotive clinical effects of pembrolizumab with necitumumab in patients having advanced non-small cell lung cancer with PD-L1 expression of 50% or higher in a phase II study (K-TAIL-202)
CANCER RESEARCH
IF16.6
2024-04-050
PRE
Horiike, Atsushi; Wakui, Hiroshi; Sugawara, Shunichi; Minegishi, Yuji; Tasaka, Sadatomo; Kusumoto, Sojiro; Sakatani, Toshio; Suzuki, Hiroyuki; Hosomi, Yukio; Tambo, Yuichi; Shimokawa, Tsuneo; Ishida, Hiroo; Miyauchi, Eisaku; Naoki, Katsuhiko; Fukuhara, Tatsuro; Mura, Emiko; Tsurui, Toshiaki; Suzuki, Risako; Iriguchi, Nana; Ishiguro, Tomoyuki; Hirasawa, Yuya; Manabe, Ryo; Shimokawa, Masahiro; Ohkuma, Ryotaro; Ariizumi, Hirotsugu; Kubota, Yutaro; Hamada, Kazuyuki; Takenoshita, Sachiko; Ryu, Kakei; Sambe, Takehiko; Inoue, Eisuke; Wada, Satoshi; Yoshimura, Kiyoshi; Sagara, Hironori; Kobayashi, Shinichi; Tsunoda, Takuya

研究方向

暂未获取到该数据
Y
Yusuke Okuma
H 指数:30论文数:397被引数:4,105
K
Kageaki Watanabe
H 指数:13论文数:95被引数:605
M
Makiko Yomota
H 指数:14论文数:77被引数:585
T
Taiki Hakozaki
H 指数:17论文数:127被引数:1,170
Y
Yuji Uehara
H 指数:7论文数:50被引数:160
Y
Yoshiro Nakahara
H 指数:13论文数:81被引数:631
T
Terufumi Kato
H 指数:58论文数:521被引数:2.9万
T
Tatsuru Okamura
H 指数:14论文数:111被引数:692
H
Hiroaki Okamoto
H 指数:34论文数:345被引数:4,816
Y
Yusuke Takagi
H 指数:23论文数:202被引数:2,085